How to appeal a Humana cancer treatments denial

The framework that applies to your appeal

Medicare Advantage plans follow a separate appeal track from commercial plans. Reconsideration must be requested within 60 days; if the plan misses its deadline, the case auto-forwards to the IRE (Maximus).

Humana-specific note: Heavily Medicare Advantage focused. MA-specific appeal track (42 CFR Part 422 Subpart M) applies — 60 days to request reconsideration, NOT the 180 days for commercial plans. Auto-forward to IRE (Maximus) if Humana misses deadline.

What Humana's policy requires for cancer treatments

Cited policy: Humana Oncology Pharmacy Prior Authorization Criteria (Medicare Advantage tied to CMS NCDs/LCDs)

Heavy MA book - must comply with Medicare NCDs/LCDs and 42 USC §1395x(t)(2). Oncology Part B drugs follow 'reasonable and necessary' + compendium standard.

How Humana denies cancer treatments — and how to counter it

Where Humana pushes back: 1) Not reasonable and necessary under Medicare standard; 2) Off-label use not in approved compendium; 3) PET imaging exceeds NCD 220.6; 4) Proton therapy not medically necessary; 5) Supportive care drug not meeting CMS criteria.

Counter-arguments that hold up: Cite 42 USC §1395x(t)(2) + specific NCCN Compendium category 1/2A/2B listing — Medicare statute requires coverage. CMS Medicare Benefit Policy Manual Ch. 15 §50.4.5 (off-label anticancer). NCD 220.6.X (specific cancer subindication) for PET. ASTRO Model Policy + NCCN radiation modality recommendation. ASCO 2015 (updated) WBC growth factors / NCCN Hematopoietic Growth Factors guideline + risk-of-FN >=20% threshold.

What Humana typically denies for cancer treatments

Across Humana's commercial and Medicare books, denials cluster around a small number of patterns. For cancer treatments, expect:

• MA plan step therapy on Part B drugs
• Skilled nursing facility days
• Prior auth on specialty drugs
• OON emergency reduction

Treatments most often denied in this category

These are the cancer treatments treatments most often flagged for prior auth, step therapy, or medical necessity review:

• Checkpoint inhibitor
• CAR-T
• Targeted oral
• ADC
• Proton therapy
• PET imaging

How to submit the appeal to Humana

1. Read the denial letter — note the exact denial reason code and the appeal deadline (60 days from the date on the letter).
2. Gather supporting documentation: physician letter of medical necessity, relevant clinical notes, peer-reviewed citations supporting the treatment for your indication, and the policy or coverage document Humana cited in the denial.
3. File the appeal through Humana's portal (members: https://www.humana.com ; providers: https://www.humana.com/provider). Standard decision returns within 30 days; expedited urgent appeals return within 72 hours.
4. If denied again, request external review by an independent reviewer within 4 months of the final internal denial. In KY, the state insurance department coordinates external review for fully-insured plans; ERISA self-funded plans use a federal external review through DOL/EBSA.

Clinician or prior-auth team handling this on the practice side? See Humana's prior-authorization criteria by drug: Humana PA criteria on ApprovalHelp.